(Editor’s note: This will have implications for Dejerine-Sottas research in the future:)
Using human embryonic stem cells, the Menlo Park company has developed a therapy that enables paralyzed rats to walk and that it claims shows no dangerous side effects in experiments with about 2,000 animals.
Others also are studying such cells for medical uses, including Stanford University scientists, who last week said they had used them to help stroke-disabled lab rats walk better. But none are as close to seeking permission for human tests as Geron, whose treatment is for spinal injuries.
For its application requesting regulatory approval from the U.S. Food and Drug Administration, the public company has gathered 25,000 pages of data – far more than normal for such requests, Geron Chief Executive Dr. Thomas Okarma said. He told analysts recently that Geron would submit it to the FDA during the first part of this year. But he declined to reveal the actual filing date, he said, “to minimize any kind of pressure on the agency.”
Yet Geron’s bid isn’t certain.
Although the FDA would not comment on Geron’s application, President Bush objects to most research with embryonic stem cells, which come from discarded embryos. Moreover, his administration has become intrigued with recent studies showing skin cells can be manipulated to have embryonic-like properties without harming an embryo.
Read the rest of One Big Step for Geron.
Do you experience neuropathic pain from Dejerine-Sottas?
One big step for Geron: Therapy that enabled paralyzed rats to walk ready for test on humans, stem-cell firm says
February 24, 2008
(Editor’s note: This will have implications for Dejerine-Sottas research in the future:)
December 5, 2007
ScienceDaily (Dec. 5, 2007) — A study carried out by researchers at the Kyoto University School of Medicine has shown that when transplanted bone marrow cells (BMCs) containing adult stem cells are protected by a 15mm silicon tube and nourished with bio-engineered materials, they successfully help regenerate damaged nerves. The research may provide an important step in developing artificial nerves.
“We focused on the vascular and neurochemical environment within the tube,” said Tomoyuki Yamakawa, MD, the study’s lead author. “We thought that BMCs containing adult stem cells, with the potential to differentiate into bone, cartilage, fat, muscle, or neuronal cells, could survive by obtaining oxygen and nutrients, with the result that rates of cell differentiation and regeneration would improve.”
Nourished with bioengineered additives, such as growth factors and cell adhesion molecules, the BMCs after 24 weeks differentiated into cells with characteristics of Schwann cells — a variety of neural cell that provides the insulating myelin around the axons of peripheral nerve cells. The new cells successfully regenerated axons and extended their growth farther across nerve cell gaps toward damaged nerve stumps, with healthier vascularity.
“The differentiated cells, similar to Schwann cells, contributed significantly to the promotion of axon regeneration through the tube,” explained Yamakawa. “This success may be a further step in developing artificial nerves.”
Read more of Bone Marrow Cell Transplants Help Nerve Regeneration
June 16, 2006
Researchers are one step closer to repairing nerve cells and treating conditions such as spinal cord injury, Parkinson’s disease and multiple sclerosis.
A new study says that stem cells found in adult skin can function after being transplanted into diseased mice.
“This shows that these stem cells found in adult skin are the real thing. We saw it in the culture dish, but now we know it’s the bona-fide real thing,” said an elated Dr. Freda Miller, senior scientist at Sick Kids hospital.
The research found that these stem cells, called skin-derived precursors or SKPs, can produce nervous system cell types called Schwann cells. These cells in turn make insulation, or myelin, and allow nerve cells to function efficiently. [Toronto Sun]
September 21, 2005
Injections of human stem cells seem to directly repair some of the damage caused by spinal cord injury, according to research that helped partially paralyzed mice walk again.
The experiment, reported Monday, isn’t the first to show that stem cells offer tantalizing hope for spinal cord injury–other scientists have helped mice recover, too.
But the new work went an extra step, suggesting the connections that the stem cells form to help bridge the damaged spinal cord are key to recovery.
Surprisingly, they didn’t just form new nerve cells. They also formed cells that create the biological insulation that nerve fibers need to communicate. A number of neurological diseases, such as multiple sclerosis, involve loss of that insulation, called myelin.
August 18, 2005
The world’s first pure nerve stem cells made from human embryonic stem cells has been created by scientists at the Universities of Edinburgh and Milan. [BBC]
June 15, 2005
From The Washington Times: Cutting-edge nanotechnology is beginning to help advance the equally pioneering field of stem-cell research, with devices that can precisely control stem cells and provide self-assembling biodegradable scaffolds and magnetic tracking systems, experts told UPI’s Nano World.
“Nanotechnology might show people once and for all that you really can help regenerate organs with stem-cell biology and help people walk again, help people after heart attacks, help people after stroke,” said John Kessler, a neurologist at Northwestern University in Evanston, Ill.
“My own daughter had a spinal-cord injury, and the thought that I could contribute to helping my daughter with this is just overwhelmingly exciting to me,” Kessler added.
Stem cells are the primordial cells of the body; every other cell type originates from them. Embryonic stem cells have the power to become any other type of cell, while adult stem cells–those collected from adults, children or umbilical cords–only can become certain kinds of cells, such as blood or fat. Scientists hope to create new therapies based on stem-cell implants that repair damaged or lost organs and tissues.
In their natural environment in the body, stem cells transform into other cell types based on chemical triggers they receive from their surroundings.
The exact cues and the placement of those cues for most stem cells are not known, “and our ability to introduce specific chemicals at select locations on a cell is extremely limited,” said materials scientist Nick Melosh at Stanford University in Palo Alto, Calif.
Researchers currently must bathe the entire surface of stem cells in various chemicals to search for a response, so Melosh and colleagues are developing a nano lab–on the scale of billionths of a meter–to experiment with individual adult stem cells. Each lab essentially consists of a capsule on a silicon chip, around which up to 1,000 nanoreservoirs hold roughly a millionth of a billionth of a milliliter of liquid, comparable to the size of secretions cells use to communicate.
“We are in essence building an artificial cell-interface unit through which we can ‘talk’ to a stem cell, in much the same way real cells do, through chemical communication,” Melosh said. “Nanotechnology is essential for this project. Larger systems just couldn’t provide the number of different reservoirs and chemicals within a space small enough to select different areas on a cell.”
Future nerve-damage repairs could be accomplished with the aid of stem cells grown in self-assembling three-dimensional biodegradable scaffolds of nanofibers developed by Sam Stupp, a materials scientist working with Kessler at Northwestern.
February 6, 2005
This just in from the Christopher Reeve Action Network:
Good News: We have a pro-stem cell bill. Let’s get behind it!
The first 100 Days of 2005 are critical for stem cell research and somatic cell nuclear transfer (SCNT or therapeutic cloning). Representatives Mike Castle (R-DE) and Diana DeGette (D-CO) are gearing up to re-introduce the Stem Cell Research Enhancement Act in the next few weeks and are asking for your help to build the list of co-sponsors.
This is our opportunity to advance positive legislation that would expand the current policy–announced without a national debate!–by President Bush on August 9, 2001. In recent days, there have been a number of articles written about the limited capacity of the current embryonic stem cell lines eligible for federal funding. (Click here for an article in the Los Angeles Times.) Now is the time to contact your Representative and tell them to support research and to be an original co-sponsor on the Castle-DeGette bill.
The legislation would allow federal funds to be used to conduct research on stem cells that meet the following criteria:
- Embryos were originally created for fertility treatment purposes and are in excess of clinical need;
- The individuals seeking fertility treatments for whom the embryos were created have determined that the embryos will not be implanted in a woman and will be discarded; and
- The individuals for whom the embryos were created have provided written consent for embryo donation.
In short, this bill asks for embryos that would be discarded to be used instead for research with the potential to save lives! We think this bill represents a modest and ethical way to pursue the promise of this field of study.
There is no time to waste. Please join us in our Campaign to Defend Hope:
Spread the word; and
Help save and improve the lives of millions—let’s keep politics out of science!
Take action now. Write your Members of Congress and ask them to proactively support upcoming legislation that would give hope and support scientific research.
Urge Your Senators and Representative to Support Research!
The Christopher Reeve Action Network
We Must. We Can. We Will.
Christopher Reeve Paralysis Foundation
500 Morris Avenue, Springfield, NJ 07081
January 31, 2005
From Scientific American: Scientists Switch Stem Cells into Neurons
Su-Chun Zhang of the University of Wisconsin-Madison and his colleagues exposed human embryonic stem cells to a variety of growth factors and hormones in sequence in order to encourage them to change into motor neurons. “You need to teach the [embryonic stem cells] to change step by step, where each step has different conditions and a strict window of time,” Zhang explains. “Otherwise, it just won’t work.” The embryonic stems cells first became neural stem cells then changed into the beginnings of motor neurons before finally differentiating into spinal motor neuron cells, the cell type that, in the human body, transmits messages from the brain to the spinal cord. The newly generated motor neurons exhibited electrical activity, the signature action of neurons, and survived in culture for more than three months.
This is a very positive step, but many obstacles remain before this can be turned into a treatment. These cells were grown in a lab, and getting them into someone in the right place and having them function is an entirely different problem. So while it’s too early to break out the champagne, we can permit ourselves a little happy dance.
December 24, 2004
Thanks again to CMTUS for this interesting article about current stem cell based reinnervation research. Looks promising! Click more to read the rest.
Abstract from Neuroscience. 2005;130(3):619-30
The immunophilin ligand FK506, but not the P38 kinase inhibitor SB203580, improves function of adult rat muscle reinnervated from transplants of embryonic neurons.
Grumbles RM, Casella GT, Rudinsky MJ, Godfrey S, Wood PM, Thomas CK.
The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami School of Medicine, Lois Pope Life Center, 1095 NW 14(th) Terrace (R48), Miami, FL 33136 USA.
Injury to the adult CNS often involves death of motoneurons, resulting in the paralysis and progressive atrophy of muscle. There is no effective therapy to replace motoneurons in the CNS. Our strategy to replace neurons and to rescue denervated muscles is to transplant dissociated embryonic day 14-15 (E14-15) ventral spinal cord cells into the distal stump of a peripheral nerve near the denervated muscles. Here, we test whether long-term delivery of two pharmacological inhibitors to denervated muscle, FK506 or SB203580, enhances reinnervation of muscle from embryonic cells transplanted in the tibial nerve of adult Fischer rats. FK506, SB203580 (2.5 mg/kg) or saline was delivered under the fascia of the medial gastrocnemius muscle for 4 weeks, beginning when muscles were denervated by section of the sciatic nerve.
February 15, 2003
The House of Representatives will be voting on Congressman Dave Weldon?s (R-FL) legislation – The Human Cloning Prohibition Act of 2003 as early as February 25th.
The bill would ban all forms of cloning, including somatic cell nuclear transfer, also called therapeutic cloning. Therapeutic cloning is vital to the development of new therapeutics that could assist millions of Americans. Congressman Weldon?s bill criminalizes the very biomedical research that may provide the best hope to finding cures for Alzheimer?s disease, ALS, diabetes, various cancers, strokes, Parkinson’s disease, traumatic brain injuries, and spinal cord injuries. We all agree, human reproductive cloning is unsafe and unethical; CAMR has repeatedly called on Congress to enact a ban on human reproductive cloning. However, a ban on therapeutic cloning would only dash the hopes of millions of Americans suffering from deadly and debilitating diseases.
H.R. 801, an alternative bill, has been introduced by Representatives Jim Greenwood (R-PA), Peter Deutsch (D-FL), Diana DeGette (D-CO), Anna Eshoo (D-CA), and Mark Kirk (R-IL). This would allow research using therapeutic cloning, while maintaining the same criminal penalties of Congressman Weldon’s bill. Congressman Greenwood will try and offer this bill as a substitute during the House debate. Tell your Representative to vote NO on H.R. 534 and to instead support research and vote YES on H.R. 801.
Somatic cell nuclear transfer is about saving and improving lives. Go to www.camradvocacy.org, and follow the steps to contact Congress.